Clinical research organizations, trial sponsors, and research sites have migrated trial master files, electronic data capture, and statistical analysis to Microsoft cloud. The licensing implications run across GCP, Part 11, sponsor expectations, and audit readiness. We negotiate the contract that matches the validated environment your QA team actually requires, not the catalog the rep is paid to sell. $420M+ recovered. 340+ engagements. Buyer side only.
Clinical research operators sit between sponsors, regulators, and sites. Microsoft prices the regulated cloud knowing every stakeholder has a different definition of acceptable risk. The leverage is in resolving those definitions inside the commercial agreement, not after it.
CROs and sponsors require validated environments for trial master files, electronic data capture, and statistical analysis systems. Sponsor audits expect documented controls, immutable audit trails, and qualification evidence. Microsoft prices each requirement into the regulated tier. The cost is paying premium for what sponsors and regulators demand while leaving real leverage unused.
Microsoft 365 across operations, biostatistics, data management, and medical affairs functions. Azure with reserved instances supporting validated trial systems. Power BI for trial operations and patient recruitment analytics. Dynamics for site management and investigator relationships. Defender, Purview, and Sentinel across the GCP aligned estate. Azure OpenAI for protocol authoring and trial document review.
Sponsor facing qualification packages, audit support letters, and validated cloud commitments exist. They are gated behind specialist teams the standard renewal motion rarely engages directly.
We map every sponsor audit expectation to a commercial term. Bundles you do not need are unwound. Validation support is bargained, not gifted. Audit posture closes inside the renewal.
CROs often run sponsor specific tenancies, isolated environments, and data residency obligations that Microsoft prices on a tenant by tenant basis. The right structure pulls those into a master commercial frame.
We advise across the clinical research map. Global top tier CROs on EA renewal across multi sponsor tenancy estates. Mid cap CROs on validated Azure environment economics. Academic research networks on grant funded Azure consumption. Sponsor research IT on cross CRO contracting harmonization. Site networks on M365 right sizing across coordinator and investigator workforces. Same discipline, scaled to the contract.
The pattern that fails: a procurement led negotiation that wins price but loses on terms that examiners, auditors, or operators later flag. The pattern that works: a posture led negotiation where pricing falls out of the work, not the other way around.
Microsoft prices clinical research on the assumption that sponsor audit pressure and regulatory expectations create structural reluctance to push back. The premise is wrong. Sponsors and regulators care that the controls exist, that they are documented, and that they are audit ready. Sponsors do not require that the controls were purchased at full list.
The most common pattern we see: a CRO paying premium across the entire tenant population when only the sponsor specific tenants require the full validated configuration. Microsoft will not propose the structural split. We will, and the renewal follows.
We start with the sponsor audit history. What controls have been examined, what findings issued, and what is documented in the master file. From there we rebuild the entitlement model bottom up against the actual sponsor population and the actual validated environment footprint.
We do not produce a GCP validation package. That is the work of internal QA and clinical operations. We translate those conclusions into commercial terms and run the deal desk negotiation against the consumption truth, not the sales narrative.
Anonymized but verifiable on reference call. Drawn from active engagements in the trailing twelve months across the practice.
The opening quote sized the regulated tier across the entire global workforce, bundled validated environment add ons across all sponsor tenancies, and committed Azure capacity against a sponsor pipeline that had been reforecast. We rebuilt the proposal from sponsor audit history, validated workload inventory, and the current operating plan.
They produced the contract structure our sponsors were already asking us to demonstrate. Microsoft had no counter to a model built from our own qualification evidence.VP of Information Technology · Global top tier CRO
Every clinical research engagement produces written deliverables your CFO, CIO, QA leader, and audit committee can read directly. Nothing lives only in our heads.
Board ready narrative of where the contract sits, what leverage exists, and what the disciplined ask is. Signed off jointly with internal stakeholders.
Concession data from signed contracts in your sector, your spend tier, and your renewal quarter. Sourced from active practice engagements.
Calendar of milestones, internal alignment checkpoints, Microsoft engagement touch points, and decision dates from posture through signature.
Live tracker of every ask, every counter, every Microsoft concession landed, and every term we have not yet closed. Updated through signature.
Two analyst calls. No pitch. We tell you what we would do, what the leverage actually is for a clinical research buyer, and whether we are the right firm for this engagement.